Abstract:Objective:To compare the characteristics of MRI signals in different therapeutic effect of desmoid-type fibromatosis (DF).Methods:One hundred and twenty-four DF patients with pathologically proven postoperative recurrent lesions from Peking University Cancer Hospital from 2008 to 2015 were enrolled in the study. All patients had baseline MRI scans, followed by once MRI scan at least every six months, and the follow-up period was three years. All patients had MRI images at the end of the third year. The therapeutic effect was evaluated by response evaluation criteria in solid tumors (RECIST) criteria, and the patients were divided into three groups: progressive disease (PD), stable disease (SD) and partial response (PR). Differences in features in the PD, SD, and PR groups were compared using one-way analysis of variance, Kruskal-Wallis, or Chi-square test. Multiple comparisons were performed using Bonferroni to correct P values. The spearman correlation coefficient was used to test the correlation between signal score and tumor maximum diameter. Results:Among the 124 patients, 17 experienced PD, 37 exhibited SD and 70 exhibited PR. There were no significant differences in age, gender distribution and the location of lesion among three groups ( P>0.05). The difference of treatment strategies was statistically significant ( P<0.05). The difference of tumor maximum diameter of baseline and the last follow-up MRI scan was also statistically significant between three groups ( P<0.05). There was no significant differences in T 2 scores and enhancement scores of baseline MRI scan among the PD, SD, and PR groups ( P>0.05). At the last follow-up MRI scan, the T 2 signal scores, the changes of T 2 signal, the scores of enhancement and the changes of enhancement of the PD, SD, and PR groups were significantly different among three groups ( P<0.05). At the last follow-up MRI scan, the tumor maximum diameter was positively correlated with the score of T 2 signal ( r=0.434, P<0.01), and the tumor maximum diameter was positively correlated with the score of enhancement ( r=0.743, P<0.01). Conclusion:MRI has great value in evaluating the therapeutic effect of DF.

CT and MRI features of different parts desmoid-type fibromatoses

Features of Ultrasound and Contrast Enhanced Ultrasound in Superficial Desmoid-Type Fibromatosis: A Series of 19 Cases

Imaging features of extra-abdominal desmoid-type fibromatosis

Imaging Features and Pathologic Correlations of Desmoid-Type Fibromatoses

Desmoid-type Fibromatoses: the Findings of Dynamic CT and MR

The CT and MRI imaging manifestation of extremity soft tissue desmoid tumor

MRI and CT manifestations of dermatofibrosarcoma protuberans

Value of Imaging Findings in Predicting Post-Operative Recurrence of Desmoid-Type Fibromatosis

The Value of MRI in Evaluating the Therapeutic Effect of Desmoid-Type Fibromatosis

Solitary Fibrous Tumor: the Imaging Diagnosis and Differential Diagnosis

18F-FDG PET/CT and 99mTc-MDP Bone Scintigraphy Findings of Multifocal Desmoid Fibromatosis

Dermatofibrosarcoma Protuberans MRI: A Preliminary Comparison of Different Sequences

Imaging manifestations of intra-abdominal aggressive fibromatosis and correlation with pathology

MRI Diagnosis of Aggressive Fibromatosis

Imaging Findings of Solitary Fibrous Tumors

Desmoid Fibromatosis Fused With a Lipoma in the Upper Arm

Solitary Fibrous Tumors in Abdomen and Pelvis:Imaging Characteristics and Radiologic-Pathologic Correlation

Imaging manifestations of cervical aggressive fibromatosis: a case report and literature review

Solitary fibrous tumors: Imaging features and differentiation between benign and malignant tumors

Intra-abdominal Desmoplastic Small Round Cell Tumors: CT and FDG-PET/CT Findings with Histopathological Association

[Imaging diagnosis of abdominal solitary fibrous tumor].